Patent · US Active

Prognostic method

US8513023B2 · kind B2 · utility

0Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2012
Grant dateAug 20, 2013
Priority date
Expiry dateOct 25, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/203332
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of determining the functional activity of the MRP2 and/or MRP3 efflux pathway of a human or animal subject was disclosed. The method comprises (i) determining the level of a bile acid derivative in the blood of said human or animal subject at a predetermined time interval after introducing an amount of the bile acid derivative into the subject, and (ii) using the determination obtained in step (i) to indicate the functional activity of the MRP2 and/or MRP3 efflux pathway of the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.